About Trypsin Chymotrypsin
Trypsin Chymotrypsin is a Healthcare company based in Panchkula (India) founded in 2021. It manufactures enzymes and probiotics for biopharmaceutical, food, and cosmetics applications. It operates on a B2B model in Healthcare and Agriculture sectors. Its Indian entity Fido Pharma Private Limited reported revenue of ₹20.59 Cr. Trypsin Chymotrypsin offers products and services including Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements. Its focus areas include Biopharmaceutical, Enzymes, Proteolytic Enzymes and Food and Agriculture Tech.
Company details
Fido Pharma Private Limited delivers enzyme solutions and probiotics tailored for applications in biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. They produce products like trypsin chymotrypsin for anti-inflammatory and healing purposes, ensuring high bioavailability. Based in Panchkula, India, with manufacturing sites in Hyderabad and Panchkula, they serve industrial clients globally through B2B channels, focusing on quality and innovation in health supplements.
- Headquarters Panchkula, India
- SectorsHealthcareAgriculture
- Email••••••••
- Phone•••• ••••
- Website trypsinchymotrypsin.com
- Legal Name Fido Pharma Pvt. Ltd.
- Date of Incorporation 04 Mar, 2020
- Jurisdiction Panchkula, Haryana, India
- Annual Revenue₹20.59 Cr
FY 2024 · +190% YoY
- Net Profit₹4.07 Cr
FY 2024 · 20% margin
- EBITDA₹4.89 Cr
FY 2024 · 24% margin
Associated legal entities of Trypsin Chymotrypsin
Trypsin Chymotrypsin operates through Fido Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fido Pharma Private Limited CIN U24230HR2020PTC085725 | Active | 04 Mar 2020 | Panchkula, Haryana | ₹20.6 Cr | 3 | View details |
Products & Services of Trypsin Chymotrypsin
Trypsin Chymotrypsin offers a comprehensive portfolio of products and services, including Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements.
Proteolytic enzymes for anti-inflammatory and healing applications.
Microbial supplements for health and industrial uses.
Blended probiotics enhancing gut health benefits.
Nutritional formulations supporting wellness and immunity.
Daily supplements for overall health maintenance.
Board of directors of Fido Pharma Private Limited (Trypsin Chymotrypsin)
Fido Pharma Private Limited is the primary company behind Trypsin Chymotrypsin. The board of Fido Pharma Private Limited currently have 3 directors; the longest-serving is Tejal Ashok Vispute, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tejal Ashok Vispute DIN 08717158 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Parbhat Singh DIN 08717156 | Director | 04 Mar 2020 | 6 yrs 7 mo | Fido Pharma Private Limited |
| Ritu Raj Singh DIN 10186291 | Director | 30 May 2023 | 3 yrs 4 mo | Fido Pharma Private Limited |
Financials of Trypsin Chymotrypsin
Figures of Fido Pharma Private Limited, the primary company behind Trypsin Chymotrypsin, for FY 2024. Revenue was ₹20.59 Cr (+190% year on year). Net profit was ₹4.07 Cr (20% margin). EBITDA was ₹4.89 Cr (24% margin). Revenue has grown at a compounded annual rate of +114% over three years.
- ₹20.59 CrRevenue · FY 2024 · +190% YoY
- ₹4.07 CrNet profit · 20% margin
- ₹4.89 CrEBITDA · 24% margin
- ₹50 LakhPaid-up capital
- +114%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Fido Pharma Private Limited are on its company page.
Detailed financial statements for Trypsin Chymotrypsin
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trypsin Chymotrypsin
Trypsin Chymotrypsin was founded in 2021.
Trypsin Chymotrypsin is headquartered in Panchkula, India. It is registered at Panchkula, Haryana, India.
The primary company behind Trypsin Chymotrypsin, Fido Pharma Private Limited, reported revenue of ₹20.59 Cr for FY 2024, up 190% year on year.
Fido Pharma Private Limited delivers enzyme solutions and probiotics tailored for applications in biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. They produce products like trypsin chymotrypsin for anti-inflammatory and healing purposes, ensuring high bioavailability. Based in Panchkula, India, with manufacturing sites in Hyderabad and Panchkula, they serve industrial clients globally through B2B channels, focusing on quality and innovation in health supplements.
Trypsin Chymotrypsin offers Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements.
Trypsin Chymotrypsin operates through Fido Pharma Private Limited.
The legal entities of Trypsin Chymotrypsin currently have 3 directors, including Tejal Ashok Vispute, Parbhat Singh, Ritu Raj Singh.